Nitrazepam

Nitrazepam, the active ingredient in Nitrazepam, is a benzodiazepine presented as an oral tablet for oral use. It is employed to manage insomnia, anxiety disorders, and certain seizure types, primarily in adult patients requiring short‑term symptom control. It is indicated for short‑term treatment of difficulty falling asleep, for relief of acute anxiety, and as an adjunct in the control of certain epileptic seizures, under medical supervision.

GNH USA supplies Nitrazepam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrazepam acts on the central nervous system to produce sedative‑hypnotic and anxiolytic effects. It is prescribed for several well‑established conditions: - Insomnia: Improves sleep onset and maintenance in patients with difficulty falling or staying asleep. - Anxiety disorders: Reduces excessive worry and tension during acute episodes. - Epilepsy (seizure control): Provides adjunctive control of certain seizure types, especially when other therapies are insufficient.

Nitrazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: Feeling unusually sleepy during daytime activities. - Dizziness: Light‑headed sensation, especially when standing quickly. - Impaired coordination: Reduced motor control and balance. - Memory impairment: Difficulty recalling recent events. - Fatigue: Persistent lack of energy. - Headache: Mild to moderate head pain.

Serious or Rare Side Effects: - Respiratory depression: Slow or shallow breathing, particularly with other depressants. - Severe allergic reaction: Rash, itching, swelling, or difficulty breathing. - Depression or suicidal thoughts: Mood changes requiring immediate medical attention. - Paradoxical agitation: Increased anxiety or aggression instead of calming. - Dependence and withdrawal: Physical reliance after prolonged use. - Hepatic dysfunction: Abnormal liver enzyme levels.

Before initiating nitrazepam therapy, several safety considerations should be addressed. - Assess renal and hepatic function: Adjust use if organ impairment is present. - Avoid abrupt discontinuation: Taper the dose under medical supervision to prevent withdrawal. - Use caution in elderly patients: Increased risk of falls and cognitive impairment. - Avoid concurrent alcohol or CNS depressants: Additive sedation may occur. - Pregnancy and lactation: Consult a healthcare professional as safety data are limited. - Store at ambient temperature: Keep in the original container, protect from moisture and direct sunlight.

Nitrazepam can interact with various medicines, influencing its efficacy and safety.

Major Interactions (Avoid): - Opioids or other CNS depressants: May cause profound sedation or respiratory depression. - Alcohol: Enhances sedative effects and impairs coordination. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): Increase nitrazepam plasma concentrations.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., carbamazepine, rifampicin): May reduce therapeutic effect. - Antidepressants (e.g., SSRIs, SNRIs): Potentially increase sedation. - Antihistamines: Additive drowsiness may occur.